STOCK TITAN

2nd Annual Gabelli Funds – Columbia Business School Healthcare Symposium (Virtual) – Friday, November 13, 2020

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary

The Gabelli Funds and Columbia Business School co-hosted a healthcare symposium discussing key topics in the industry, including vaccines, health policy, and virtual healthcare delivery. Key speakers included executives from Pfizer, Moderna, and Teladoc Health. The agenda featured panels on vaccines for COVID-19, trends in health policy and reimbursement, and the evolution of healthcare delivery in a virtual world. This event is part of Gabelli's effort to address pressing healthcare issues and enhance dialogue among industry leaders.

Positive
  • Featured prominent industry leaders from Pfizer, Moderna, and Teladoc Health, enhancing Gabelli Funds' reputation.
  • Addressed pressing healthcare issues, potentially improving Gabelli's strategic positioning in the market.
  • Facilitated networking and knowledge sharing among key stakeholders in healthcare.
Negative
  • None.

GREENWICH, Conn.--()--Join us as we discuss today’s pressing healthcare issues.

CO-HOSTS:

Bunny Ellerin

Director, HPM, Columbia Business School

Jing He

Biotech Analyst, Gabelli Funds

  • MBA, Harvard Business School
  • BA, Columbia University
  • MBA, Columbia Business School
  • MA, Washington University in St. Louis
  • BS, Peking University

Time

Agenda

9:00 – 9:10 AM

Welcome

  • Bunny Ellerin, Director, Healthcare and Pharmaceutical Management Program

9:10 – 10:00 AM

Vaccines & Therapeutics to Treat COVID-19

  • David Hering, Regional President, North America, Pfizer Vaccines
  • Dr. Robert Paris, Vice President, Infectious Diseases, Moderna
  • Dr. David Weinreich, Senior Vice President, Global Clinical Development, Regeneron
  • (Moderator) Jing He ‘15, Biotech Analyst, Gabelli Funds

10:10 – 11:00 AM

Health Policy & Reimbursement Trends

  • Dr. Deepa Kumaraiah, Senior Vice President, Service Lines and Chief Physician, NYP Medical Groups, NewYork-Presbyterian
  • Melissa Schulman, Senior Vice President of Government Affairs, CVS Health
  • Professor Michael Sparer, Chair, Health Policy and Management, Columbia University Mailman School of Public Health
  • (Moderator) Jeff Jonas, Portfolio Manager, Gabelli Funds

11:10 – Noon

Healthcare Delivery in a Virtual World

  • Dr. Amy Fahrenkopf, President, HSS Health and Senior Vice President, Hospital for Special Surgery
  • Jason Gorevic, CEO, Teladoc Health
  • Dr. Julie Silverstein, Divisional President, Oak Street Health
  • (Moderator) Kevin Kedra, Healthcare Analyst, G.research

Click Here to Register

Gabelli Funds, LLC is a registered investment adviser with the Securities and Exchange Commission and is a wholly owned subsidiary of GAMCO Investors, Inc. (NYSE: GBL).

Contacts

Douglas R. Jamieson
914-921-5020
djamieson@gabelli.com

FAQ

What was the focus of the Gabelli Funds and Columbia Business School healthcare symposium?

The symposium focused on vaccines and therapeutics for COVID-19, health policy trends, and virtual healthcare delivery.

Who were the notable speakers at the healthcare symposium hosted by Gabelli Funds?

Notable speakers included David Hering from Pfizer, Dr. Robert Paris from Moderna, and Jason Gorevic from Teladoc Health.

When did the Gabelli Funds healthcare symposium take place?

The symposium took place from 9:00 AM to Noon on the day of the press release.

What company is associated with the stock symbol GBL?

Gabelli Funds, LLC is the company associated with the stock symbol GBL.

How does the healthcare symposium impact GBL investors?

The symposium may enhance Gabelli's reputation and strategic positioning, potentially benefiting GBL investors.

GBL

NYSE:GBL

GBL Rankings

GBL Latest News

GBL Stock Data

389.63M
4.97M
4.23%
74.61%
0.25%
Asset Management
Financial Services
Link
United States
Rye